Answers are grounded in this paper and cite their sources.
Zinc oxide nanoparticles are promising antimicrobial and bioactive agents for public health, but current methods involve toxic reagents and the aggregation of the nanoparticles. In this study, we developed zinc oxide nanoparticles using aqueous extracts from neem ( Azadirachta indica ) leaves and encapsulated the nanoparticles with chitosan for enhanced stability and performance. Using diffraction, spectroscopic, thermal, and microscopic techniques, we found that the resulting nanoparticles have a hexagonal wurtzite phase structure with smaller crystallite sizes (28.6–20.3 nm) and greater band-gap values (3.09–3.16 eV) and are evenly dispersed in the chitosan matrix with 54% zinc oxide loading. The encapsulated nanoparticles showed improved antibacterial and antifungal activities with a 26 mm inhibition zone against Staphylococcus aureus and lower minimum inhibitory concentration values compared to pure zinc oxide nanoparticles. They also inhibited the α-amylase enzyme (half-maximal inhibitory concentration [IC 50 ] = 34.37 μg/mL) and were strong antioxidants (IC 50 = 52.34 μg/mL).
No takes yet. Share an insight, caveat, or question.
Afzal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: